Polyethylene glycol liposome doxorubicin

pegylated liposomal doxorubicin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Polyethylene glycol liposome doxorubicin, covering 2019-04-02 to 2019-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma [Phase 4]